498 related articles for article (PubMed ID: 9133508)
1. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Gottdiener JS; Reda DJ; Massie BM; Materson BJ; Williams DW; Anderson RJ
Circulation; 1997 Apr; 95(8):2007-14. PubMed ID: 9133508
[TBL] [Abstract][Full Text] [Related]
2. Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents.
Gottdiener JS; Reda DJ; Williams DW; Materson BJ; Cushman W; Anderson RJ
Circulation; 1998 Jul; 98(2):140-8. PubMed ID: 9679720
[TBL] [Abstract][Full Text] [Related]
3. Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial.
Cushman WC; Materson BJ; Williams DW; Reda DJ
Hypertension; 2001 Oct; 38(4):953-7. PubMed ID: 11641316
[TBL] [Abstract][Full Text] [Related]
4. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Materson BJ; Reda DJ; Cushman WC; Massie BM; Freis ED; Kochar MS; Hamburger RJ; Fye C; Lakshman R; Gottdiener J
N Engl J Med; 1993 Apr; 328(13):914-21. PubMed ID: 8446138
[TBL] [Abstract][Full Text] [Related]
5. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
Papademetriou V; Gottdiener JS; Narayan P; Cushman WG; Zachariah PK; Gottdiener PS; Chase GA
J Am Coll Cardiol; 1997 Dec; 30(7):1802-8. PubMed ID: 9385910
[TBL] [Abstract][Full Text] [Related]
6. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Lakshman MR; Reda DJ; Materson BJ; Cushman WC; Freis ED
Arch Intern Med; 1999 Mar; 159(6):551-8. PubMed ID: 10090111
[TBL] [Abstract][Full Text] [Related]
7. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
9. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Preston RA; Materson BJ; Reda DJ; Williams DW; Hamburger RJ; Cushman WC; Anderson RJ
JAMA; 1998 Oct; 280(13):1168-72. PubMed ID: 9777817
[TBL] [Abstract][Full Text] [Related]
10. Absence of detectable regression of human hypertensive left ventricular hypertrophy following drug treatment for 1 year.
Laufer E; Reid C; Qi XL; Jennings GL
Clin Exp Pharmacol Physiol; 1998; 25(3-4):208-15. PubMed ID: 9590570
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of mibefradil and atenolol on regression of left ventricular hypertrophy in hypertensive patients.
Höglund C; Cifkova R; Mimran A; Tenczer J; Watt A; Wilkins MR; Lindberg E
Cardiology; 1998 May; 89(4):263-70. PubMed ID: 9643273
[TBL] [Abstract][Full Text] [Related]
12. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
[TBL] [Abstract][Full Text] [Related]
13. Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Materson BJ; Reda DJ; Preston RA; Cushman WC; Massie BM; Freis ED; Kochar MS; Hamburger RJ; Fye C; Lakshman R
Arch Intern Med; 1995 Sep; 155(16):1757-62. PubMed ID: 7654109
[TBL] [Abstract][Full Text] [Related]
14. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
16. Hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment. Influence on LVH, proteinuria and metabolic parameters. The HANE Trial Research Group.
Kribben A; Anlauf M; Distler A; Gärtner H; Holzgreve H; Michaelis J; Röcker L; Schäfers R; Philipp U; Wellek S; Philipp T
Kidney Int Suppl; 1997 Oct; 61():S74-6. PubMed ID: 9328972
[No Abstract] [Full Text] [Related]
17. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea.
Kraiczi H; Hedner J; Peker Y; Grote L
Am J Respir Crit Care Med; 2000 May; 161(5):1423-8. PubMed ID: 10806134
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
Os I; Hotnes T; Dollerup J; Mogensen CE
Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
[TBL] [Abstract][Full Text] [Related]
19. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
[TBL] [Abstract][Full Text] [Related]
20. Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.
Agabiti-Rosei E; Zulli R; Muiesan ML; Salvetti M; Rizzoni D; Corbellini C; Monteduro C
Blood Press; 1998 May; 7(3):160-9. PubMed ID: 9758086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
